GSK Lamictal Prices Don't Breach Deal, Judge Says
A federal judge has thrown out a suit alleging that GlaxoSmithKline PLC's effort to sell its Lamictal epilepsy drug at generic prices breached a license agreement giving Teva Pharmaceutical Industries Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article